Search for: "MYLAN, INC."
Results 501 - 520
of 674
Sort by Relevance
|
Sort by Date
29 Jul 2010, 10:24 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Namenda (Memantine) – US: Mylan announces settlement agreement with Forest Lab’s and Merz Pharmaceuticals (SmartBrief) Olux-E (Clobetasol) – US: Patent infringement complaint following a Paragraph IV certification: Stiefel Laboratories Inc. et al. v. [read post]
22 Jul 2010, 8:15 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
22 Jul 2010, 11:59 am
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
9 Jul 2010, 3:24 pm
As one of the leading manufacturers of generic drugs in the world, Mylan received final approval by the Food and Drug Administration (FDA) in 2009 to manufacture a generic substitute for the anti-seizure medication, Keppra, developed by UCB Pharmaceuticals Inc. and marketed to epilepsy patients. [read post]
8 Jul 2010, 7:38 am
Inc., C.A. [read post]
30 Jun 2010, 5:52 am
Mylan Inc. et al. [read post]
29 Jun 2010, 6:01 pm
Mylan Inc. et al. [read post]
24 Jun 2010, 1:47 pm
On June 18, 2010 the Supreme Court of Appeals of West Virginia filed its decision in favor of CGL and Umbrella insurers in Mylan Laboratories, Inc v. [read post]
23 Jun 2010, 10:28 pm
Mylan Inc. et al. [read post]
20 Jun 2010, 8:51 pm
LLC; Sugen Inc.; C P Pharmaceuticals International CV • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
8 Jun 2010, 11:05 pm
Mylan Labs., Inc., 520 F.3d 1358, 1365 (Fed. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
31 May 2010, 5:51 am
Mylan, Inc., 2010 U.S. [read post]
20 May 2010, 12:09 pm
Mylan, Inc., No. 080500804, slip op. [read post]
7 May 2010, 1:07 pm
Barr Laboratories, Inc. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
5 May 2010, 4:46 am
Mylan Pharmaceuticals Inc. et al. [read post]
3 May 2010, 5:08 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364 (Fed. [read post]
